Skip to main content
Fig. 2 | BMC Gastroenterology

Fig. 2

From: Investigating the effect of quadruple therapy with Saccharomyces boulardii or Lactobacillus reuteri strain (DSMZ 17648) supplements on eradication of Helicobacter pylori and treatments adverse effects: a double-blind placebo-controlled randomized clinical trial

Fig. 2

Flow chart of the study. A total of 156 patients met the inclusion criteria. HpSA: H. pylori stool antigen, Endo: endoscopic, GDQ: Glasgow dyspepsia questionnaire, PPI: proton pomp inhibitor, Amox: amoxicillin, Clarith: clarithromycin, b.i.d: twice daily, BSC: bismuth subcitrate

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us